Fast Moving Consumer GoodsFood ProductsPackaged Foods

Sampre Nutritions Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 42 filings·Updated 15 Oct 2026
Showing 10 of 42 filings.
15 Oct 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Confirmation certificate enclosed from registrar and transfer agent for dematerialisation/rematerialisation reporting

Status update

  • Confirmation certificate from the registrar and transfer agent enclosed.
Filed 18:54View Source
27 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Sampre Nutritions Limited: Trading Window Closed from 01 October 2026 till 48 hours after the declaration of unaudited standalone and consolidated financial results for the second quarter of FY 2026-27 (quarter ended 30 September 2026).

Sampre Nutritions Limited: Trading Window Closed from 01 October 2026 till 48 hours after the declaration of unaudited standalone and consolidated financial results for the second quarter of FY 2026-27 (quarter ended 30 September 2026).

Filed 08:15View Source
25 Sept 20261 filing
OthersOutcome without intimation

Board approves preferential allotment of 1,770,710 equity shares on conversion of unsecured loan to Brahma and Meera Gurbani.

Capital Action

  • Board approved preferential allotment on conversion of unsecured loan.
  • Allotment size: 1,770,710 equity shares at INR 42 per share.
  • Face value INR 5; premium INR 37.
  • Allottees: Brahma Gurbani and Meera Gurbani.
  • Aggregate value: INR 7,43,69,820.
  • Pursuant to members' special resolution dated 10 December 2025.
  • Post-allotment shareholding: Brahma Gurbani 7.48%, Meera Gurbani 3.47%.
  • Board meeting date: 25 September 2026.
Filed 18:29View Source
29 Aug 20261 filing
Company UpdatePreferential Issue

In-principle BSE approval for promoter and promoter group equity issue via loan conversion

Key details

  • In-principle approval from BSE for issue of equity shares to promoter and promoter group on a preferential basis.
  • Equity shares to be issued via conversion of unsecured loans.
  • Allottees: promoter and promoter group category.
  • Date of approval communicated: 28 August 2026.
  • Purpose: convert unsecured loans into equity for promoter group.
  • Nature of consideration: conversion of loans into equity.
  • Approvals required: BSE in-principle approval obtained.
Filed 18:33View Source
14 Aug 20262 filings
AGM/EGMAGM

Sampre Nutritions schedules 35th AGM for 04 Sep 2026 via VC/OAVM with e-voting window

AGM Details

  • 35th AGM scheduled for 04 September 2026 at 11:00 IST via VC/OAVM.
  • Cut-off date for remote e-voting and attendance is 28 August 2026.
  • Remote e-voting opens 01 September 2026 at 09:00 IST.
  • Remote e-voting closes 03 September 2026 at 05:00 PM IST.

Access to AGM Materials

  • Annual report for FY 2025-26 accessible on company and BSE websites.
  • Notice and AGM materials accessible via QR code and provided links.
Filed 13:34View Source
AGM/EGMAGM

Sampre Nutritions to hold 35th AGM via VC/OAVM on Sep 4, 2026.

AGM Details

  • AGM scheduled for 04 Sep 2026 at 11:00 AM IST via VC/OAVM.
  • Notice dated 14 August 2026.
  • Corrigendum issued for typographical errors in scrutinizer appointment dates.
  • Corrected Annual Report 2025-26 dispatched to members and uploaded to the company website.
Filed 13:26View Source
12 Aug 20261 filing
Company UpdateNewspaper Publication

Newspaper advertisement for the Notice of 35th AGM sent to the members of the Company to be held on Friday, 04 September 2026, at 11:00 A.M. (IST).

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 11:27View Source
10 Aug 20262 filings
OthersReg. 34 (1) Annual Report

Sampre Nutritions Ltd 2025-26 Annual Report: Financials, Capital Reforms, Governance & Group Structure

Financial highlights

  • Standalone total income 4,405.76 L; PAT 386.56 L; Basic EPS 1.84; Diluted 2.73.
  • Consolidated total income 4,377.92 L; PAT 307.68 L; EPS 2.18.
  • Dividend: no dividend recommended for 2025-26.
  • Total assets 12,697.88 L; Total equity 10,023.76 L.
  • Equity share capital ended at 95,008,913 shares (Rs 4,750.45 L).
  • Net debt 2,667.86 L; gearing 0.21x.
  • Standalone cash flow: operating -94.10 L; investing -275.42 L; financing 370.13 L; net change 0.62 L.

Capital actions

  • 840,000 convertible warrants converted to equity; 550k on 12-09-2025; 290k on 25-09-2025.
  • Share capital increased to Rs 4,750.45 L via 74,002,058 new shares.
  • Share sub-division: Rs 10 to Rs 5 per share on 14 Nov 2025.
  • Bonus issue: 43,693,710 shares issued 1:1 on 14 Nov 2025.
  • FCCBs converted: 7,621,493 equity shares; 2 FCCBs remain outstanding.
  • Record date for sub-division: 14 November 2025.

Governance & board changes

  • Board: six directors; two Executive, four Independent; one Woman Director, Vanita Khatter.
  • Vinay Kumar Verma ceased as Independent Director on 19 August 2025.
  • Pradeep Narendra Poddar appointed Additional Director on 13 February 2026; approved 10 May 2026.
  • Audit Committee: four members; Chair Nagaraju Kanneganti.
  • Nomination & Remuneration Committee: four Independent Directors; Chair Vanita Khatter.
  • Stakeholders' Relationship Committee: four Independent Directors; Chair Kireet Modi.

Subsidiaries and group

  • Subsidiaries: Sampre Nutritions FZCO (Dubai) and Sampre Nutritions Holding Limited (UK).
  • Form AOC-1 Annexure 4 provides salient features of subsidiaries and group.

Audit & compliance

  • Statutory auditor: N G Rao & Associates; Secretarial auditor: Neelu Goyal & Associates.
  • MD & CFO certifications attached to the annual report.
  • MR-3 secretarial audit reported a modified opinion for 2024-25; actions planned.
  • Internal financial controls are adequate and operating effectively.
  • Audit fees total 5.00 L: 4.50 L statutory; 0.20 L certifications; 0.30 L others.

CSR & sustainability

  • CSR not applicable; no CSR policy or committee for 2025-26.
  • Company highlights ongoing sustainability and governance focus.

Related party transactions

  • Arm's-length related party transactions; notable items include director remuneration.
  • Balances receivable/payable with related parties: Royes 953.43 L; directors 900.09 L; 80.57 L.

Risks & outlook

  • Outlook: long-term prospects positive; margins pressured by raw material costs; focus on efficiency.
  • Management focuses on capital allocation, risk management, and cash flow discipline.
Filed 19:02View Source
AGM/EGMAGM

Sampre Nutritions to hold 35th AGM via VC/OAVM on 4 Sept 2026; financials and remuneration

AGM Details

  • Date and time: 04 September 2026 at 11:00 IST, via VC/OAVM.
  • Cut-off for remote voting/attendance: 28 August 2026.
  • Remote e-voting period: 01 Sep 2026 09:00 IST to 03 Sep 2026 05:00 PM IST.

Key Resolutions

  • Item 1 (Ordinary): Adopt audited financial statements for year ended 31 March 2026.
  • Item 2 (Ordinary): Reappoint Vishal Ratan Gurbani as Director on rotation.
  • Item 3 (Special): Remuneration revision for Vishal Ratan Gurbani to ₹60 L, effective 01 Apr 2026.

Voting Results

  • Outcome: to be declared; subject to requisite votes.

Dividend

  • No dividend proposal mentioned.

Director Changes

  • Reappointment of Vishal Ratan Gurbani as Director (Whole-Time Director) on rotation.

Auditors

  • No auditor appointments or changes disclosed in this chunk.

Material Related Party Transactions

  • No material related party transactions disclosed.

Other Approvals

  • Board authorized to implement remuneration revision and execute related documents.
Filed 18:54View Source
7 Aug 20261 filing
Company UpdateNewspaper Publication

Newspaper publication of the unaudited standalone and consolidated financial results of the company for the first quarter ended 30 June 2026 for the financial year 2026-27.

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 16:54View Source
Showing 10 of 42 filings